Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
Postprint
DOI
PMC
 |
Open Access Green |
as soon as is submitted to ZB.
Targeting innate and adaptive immune responses to cure chronic HBV infection.
Gastroenterology 156, 325-337 (2018)
Fewer than 1% of chronic hepatitis B virus infections per year are cured with antiviral treatment. This creates a need for long-term treatment, which poses challenges for patients and health systems. Because cure is accompanied by recovery of antiviral immunity, a combination of direct-acting antiviral agents and immunotherapy are likely to be required. Extensive efforts have been made to identify determinants of the failed immune response to hepatitis B virus in patients with chronic infection. We review mechanisms of immune dysfunction in patients with chronic hepatitis B virus infection, immunotherapy strategies in development, and the challenges associated with successful implementation of immunotherapy.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Review
Keywords
Drug ; Hbsag ; Vaccine ; Inflammation; Hepatitis-b-virus; Cd8(+) T-cells; Adoptive Transfer; Viral-hepatitis; Surface-antigen; Hepatocellular-carcinoma; Programmed Death-1; Liver; Replication; Hepatocytes
ISSN (print) / ISBN
0016-5085
e-ISSN
1528-0012
Journal
Gastroenterology
Quellenangaben
Volume: 156,
Issue: 2,
Pages: 325-337
Publisher
Elsevier
Publishing Place
1600 John F Kennedy Boulevard, Ste 1800, Philadelphia, Pa 19103-2899 Usa
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Virology (VIRO)